share_log

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

Evercore ISI Group将Bionomics的评级下调至同步,将目标价下调至6美元
Benzinga Real-time News ·  2022/12/20 05:07

Evercore ISI Group analyst Joshua Schimmer downgrades Bionomics (NASDAQ:BNOX) from Outperform to In-Line and lowers the price target from $17 to $6.

Evercore ISI Group分析师Joshua Schimmer将Bionomics(纳斯达克:BNOX)的评级从强于大盘下调至同线,并将目标价从17美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发